Interim financing deal gives Refocus breathing space
This article was originally published in Clinica
Executive Summary
Refocus Group has secured eleventh-hour interim financing that staves off the cessation of its activities for the time being. The company, which is developing a surgical system to treat presbyopia and other eye disorders, had previously said it would not be able to continue operating beyond October 2004 without fresh funding.